The Efficacy of Oral Antioxidant on Glycemic Index and Lipid Profile in Patients With Type Ii Diabetes Mellitus: A Systematic Review
##submission.downloads##
- Abstrakt
- ##submission.howToCite##
- ##plugins.themes.noble.metrics##
- ##submission.citations##
- ##submission.license##
Background: Type 2 diabetes is caused by insulin resistance or insufficient insulin for glucose metabolism, with its pathogenesis linked to free radical exposure. High free radical concentrations and low antioxidant levels increase the risk of complications in diabetes mellitus. Despite this, antioxidant supplementation in diabetic patients remains uncommon. This systematic review explores the efficacy of antioxidant supplementation on therapeutic outcomes in type II diabetes mellitus patients. Methods: A literature search was conducted from January to February 2024 across three databases: PubMed, Science Direct, and Google Scholar. Inclusion criteria focused on adult patients aged >18 years diagnosed with type II diabetes mellitus, randomized controlled trials (RCTs), studies on antioxidant supplementation (excluding non-supplement forms), and studies covering glycemic indices (FPG, PPG, 2hPG, HbA1c) and lipid profiles (LDL, HDL, cholesterol, TG) published from 2014 to 2024 in English or Indonesian. Pediatrics and in vitro/in vivo studies were excluded. Results: The bias risk was assessed using the 2020 PRISMA guidelines. Six journals met the inclusion criteria. The review found that supplementation with turmeric, ellagic acid, Nigella sativa, zinc, vitamins C, and E significantly affected glucose and lipid levels in type II diabetes mellitus patients. However, selenium supplementation showed inconsistent results regarding blood glucose levels and lipid profiles, indicating the need for further investigation. Conclusion: Supplementation with turmeric, ellagic acid, Nigella sativa, zinc, vitamins C, and E is effective in controlling blood glucose levels and improving lipid profiles in type II diabetes mellitus patients.
Abdulmalek, S. A., & Balbaa, M. (2019). Synergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markers. PLOS ONE, 14(8), e0220779. https://doi.org/10.1371/journal.pone.0220779
Adab, Z., Eghtesadi, S., Vafa, M., Heydari, I., Shojaii, A., & Haqqani, H. (2019). Effect of turmeric on glycemic status, lipid profile, hs-CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytotherapy Research, 33(4), 1173–1181. https://doi.org/10.1002/ptr.6303
AL-Bahrani, S. M., & Yassin, B. A. G. (2022). Lipid profile and glycemic control in type 2 diabetic patients. Arab Board Medical Journal, 23(1), 21–27.
Aschner, P., Galstyan, G., Yavuz, D. G., Litwak, L., Gonzalez-Galvez, G., Goldberg-Eliaschewitz, F., et al. (2021). Glycemic control and prevention of diabetic complications in low- and middle-income countries: An expert opinion. Diabetes Therapy, 12(5), 1491–1501. https://doi.org/10.1007/s13300-021-01032-8
Avcil, M. (2022a). Benefits and risk of human health by antioxidants. Oxidants and Antioxidants in Medical Science, 11(1), 1–2.
Avcil, M. (2022b). Role of antioxidants and its functions in human body. Oxidants and Antioxidants in Medical Science, 11(7), 1–6.
Balbi, M. E., Tonin, F. S., Mendes, A. M., Borba, H. H., Wiens, A., Fernandez-Llimos, F., et al. (2018). Antioxidant effects of vitamins in type 2 diabetes: A meta-analysis of randomized controlled trials. Diabetology & Metabolic Syndrome, 10(1), 18. https://doi.org/10.1186/s13098-018-0318-5
Delpino, F. M., Figueiredo, L. M., da Silva, B. G. C., da Silva, T. G., Mintem, G. C., Bielemann, R. M., et al. (2022). Omega-3 supplementation and diabetes: A systematic review and meta-analysis. Critical Reviews in Food Science and Nutrition, 62(16), 4435–4448. https://doi.org/10.1080/10408398.2021.1871943
El-Aal, A. A., El-Ghffar, E. A. A., Ghali, A. A., Zughbur, M. R., & Sirdah, M. M. (2018). The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: A single-blinded randomized controlled clinical trial. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 12(4), 483–489. https://doi.org/10.1016/j.dsx.2018.03.003
Elsayed Azab, A., Adwas, A. A., Ibrahim Elsayed, A. S., Ata Sedik, I. E., & Quwaydir, F. A. (2019). Oxidative stress and antioxidant mechanisms in human body. Journal of Applied Biotechnology & Bioengineering, 6(1), 43–47.
Fatima, N., Hafizur, R. M., Hameed, A., Ahmed, S., Nisar, M., & Kabir, N. (2017). Ellagic acid in Emblica officinalis exerts anti-diabetic activity through the action on β-cells of pancreas. European Journal of Nutrition, 56(2), 591–601. https://doi.org/10.1007/s00394-015-1109-y
Faghihi, T., Radfar, M., Barmal, M., Amini, P., Qorbani, M., Abdollahi, M., et al. (2014). A randomized, placebo-controlled trial of selenium supplementation in patients with type 2 diabetes. American Journal of Therapeutics, 21(6), 491–495.
Fasil, A., Biadgo, B., & Abebe, M. (2018). Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 75–83.
Fernández-Cao, J. C., Warthon-Medina, M., Moran, V. H., Arija, V., Doepking, C., Serra-Majem, L., et al. (2019). Zinc intake and status and risk of type 2 diabetes mellitus: A systematic review and meta-analysis. Nutrients, 11(5), 1027. https://doi.org/10.3390/nu11051027
Franco, R., Casanovas, B., Camps, J., & Navarro, G. (2021). Antioxidant supplements versus health benefits of brief/intermittent exposure to potentially toxic physical or chemical agents. Current Issues in Molecular Biology, 43(2), 650–664. https://doi.org/10.3390/cimb43020047
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., & Uribe, K. B. (2020). Pathophysiology of type 2 diabetes mellitus. International Journal of Molecular Sciences, 21(17), 6275. https://doi.org/10.3390/ijms21176275
Gęgotek, A., & Skrzydlewska, E. (2022). Antioxidative and anti-inflammatory activity of ascorbic acid. Antioxidants, 11(10), 1993. https://doi.org/10.3390/antiox11101993
Ghadimi, M., Foroughi, F., Hashemipour, S., Rashidi Nooshabadi, M., Ahmadi, M. H., & Ahadi Nezhad, B. (2021). Randomized double-blind clinical trial examining the ellagic acid effects on glycemic status, insulin resistance, antioxidant, and inflammatory factors in patients with type 2 diabetes. Phytotherapy Research, 35(2), 1023–1032. https://doi.org/10.1002/ptr.6871
Herningtyas, E. H., & Ng, T. S. (2019). Prevalence and distribution of metabolic syndrome and its components among provinces and ethnic groups in Indonesia. BMC Public Health, 19(1), 377. https://doi.org/10.1186/s12889-019-6711-7
World Health Organization. (2023). Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes
Yi, X., Dong, M., Guo, N., Tian, J., Lei, P., Wang, S., et al. (2023). Flavonoids improve type 2 diabetes mellitus and its complications: A review. Frontiers in Nutrition, 10, 1181716. https://doi.org/10.3389/fnut.2023.1181716
##submission.copyrightStatement##
##submission.license.cc.by-sa4.footer##
